Related Experiment Video
Updated: Sep 15, 2025
Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions
Published on: June 7, 2020
Mutations in Hsp40 co-chaperone change the unique canonical inter-domain interactions stimulating LGMDD1 myopathy
Insights
Mutations in the DNAJB6 gene cause Limb-girdle muscular dystrophy D1 (LGMDD1). Understanding how these mutations affect protein function is crucial for developing treatments for this rare neuromuscular disorder.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- Limb-girdle muscular dystrophy D1 (LGMDD1) is a rare, autosomal dominant neuromuscular disorder.
- It is caused by mutations in the DNAJB6 gene, which encodes an HSP40 co-chaperone protein.
- Currently, no effective treatments exist for LGMDD1, and the specific muscle client proteins of DNAJB6 remain unidentified.
Purpose of the Study:
- To investigate the functional consequences of novel mutations in the J-domain of DNAJB6.
- To elucidate the impact of these mutations on chaperone activity, substrate binding, and Hsp70 interaction.
- To provide mechanistic insights into LGMDD1 pathogenesis and identify potential therapeutic targets.
Main Methods:
- Analysis of J-domain mutants of DNAJB6 in vitro.
- Assays for chaperone function, client-substrate binding affinity, and Ssa1 ATP hydrolysis stimulation.
- Molecular simulation studies to examine inter-domain interactions.
Main Results:
- Novel J-domain mutations in DNAJB6 impair chaperone function, leading to variable substrate processing.
- Mutants exhibit reduced binding affinity to client substrates and decreased stimulation of Ssa1 ATP hydrolysis.
- These effects are substrate-conformer-specific and linked to altered inter-domain interactions influencing the Hsp40-Hsp70 ATPase cycle.
Conclusions:
- J-domain mutations in DNAJB6 disrupt Hsp40 chaperone activity through altered inter-domain dynamics.
- These findings enhance the understanding of LGMDD1 pathophysiology.
- Modulating the inter-domain interface of mutant DNAJB6 presents a potential therapeutic strategy for LGMDD1.
Abstract:
Limb-girdle muscular dystrophy D1 (LGMDD1) is a rare, dominantly inherited neuromuscular disorder caused by mutations in the HSP40 co-chaperone DNAJB6, primarily in the GF or J-domains. Currently, no treatments are available, and a challenge in understanding the disease is identifying a specific client protein for DNAJB6 in skeletal muscle. Our previous research indicated that LGMDD1 GF domain mutants in Sis1 exhibit substrate-specific effects, influenced by HSP70 activity. Herein, we found that novel mutations in the J-domain similarly affected chaperone function. The J-domain mutants exhibited variable substrate processing, reduced binding affinity to client-substrate, and decreased stimulation of Ssa1 ATP hydrolysis, with these effects being substrate-conformer-specific. Our simulation studies noted differences in inter-domain interactions linked to the mutants, which influence the Hsp40-Hsp70 ATPase cycle. These mechanistic insights enhance our understanding of LGMDD1 myopathy and help to identify potential treatment strategies in the future.
Teaser:
Recalibrating the inter-domain interface of the mutant protein could potentially serve as a key therapeutic strategy for LGMDD1 myopathy.
